FDA Approves Unknown Drug — EPIC PHARMA LLC

# FDA Approves Epic Pharma's Generic Drug Application Epic Pharma LLC has received FDA approval for an abbreviated new drug application (ANDA 219556), marking another addition to the company's generic portfolio and positioning it to capture additional market share in the competitive generic pharmaceutical sector. The approval is expected to expand treatment accessibility while intensifying price competition in its therapeutic category.